Vistin Pharma ASA - Asset Resilience Ratio

Latest as of March 2025: 3.08%

Vistin Pharma ASA (VISTN) has an Asset Resilience Ratio of 3.08% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See VISTN working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Nkr12.67 Million

≈ $1.33 Million USD Cash + Short-term Investments

Total Assets

Nkr411.55 Million

≈ $43.31 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how Vistin Pharma ASA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Vistin Pharma ASA's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Vistin Pharma ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read VISTN total debt and obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Nkr12.67 Million	3.08%
Short-term Investments	Nkr0.00	0%
Total Liquid Assets	Nkr12.67 Million	3.08%

Asset Resilience Insights

Limited Liquidity: Vistin Pharma ASA maintains only 3.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Vistin Pharma ASA Industry Peers by Asset Resilience Ratio

Compare Vistin Pharma ASA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Vistin Pharma ASA (2016–2023)

The table below shows the annual Asset Resilience Ratio data for Vistin Pharma ASA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	6.50%	Nkr26.20 Million ≈ $2.76 Million	Nkr403.40 Million ≈ $42.45 Million	+6.14pp
2022-12-31	0.35%	Nkr1.44 Million ≈ $151.00K	Nkr407.21 Million ≈ $42.85 Million	-23.58pp
2020-12-31	23.93%	Nkr77.04 Million ≈ $8.11 Million	Nkr321.92 Million ≈ $33.87 Million	-12.75pp
2019-12-31	36.68%	Nkr184.91 Million ≈ $19.46 Million	Nkr504.17 Million ≈ $53.05 Million	-10.03pp
2018-12-31	46.71%	Nkr233.58 Million ≈ $24.58 Million	Nkr500.06 Million ≈ $52.62 Million	+14.71pp
2016-12-31	32.00%	Nkr89.44 Million ≈ $9.41 Million	Nkr279.52 Million ≈ $29.41 Million	--

pp = percentage points

About Vistin Pharma ASA

OL:VISTN Norway Drug Manufacturers - Specialty & Generic

Market Cap

$87.26 Million

Nkr829.24 Million NOK

Market Cap Rank

#19780 Global

#176 in Norway

Share Price

Nkr18.70

Change (1 day)

-1.58%

52-Week Range

Nkr18.70 - Nkr23.70

All Time High

Nkr28.06